Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)

BACKGROUND: CD10 was initially recognised as a cell–surface antigen expressed by acute lymphoblastic leukaemias, and hence it’s early designation as Common Acute Lymphoblastic Leukemia Antigen (CALLA). Also, it has been proven to be reactive in various non-lymphoid cells and tissue and different typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabal, Samia Mohamed, Salem, Mostafa Mohamed, Mostafa, Rasha Ramadan, Abdelsalam, Shaimaa Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311489/
https://www.ncbi.nlm.nih.gov/pubmed/30607179
http://dx.doi.org/10.3889/oamjms.2018.456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311489/
https://www.ncbi.nlm.nih.gov/pubmed/30607179
http://dx.doi.org/10.3889/oamjms.2018.456

Ejemplares similares